Dr. Ann Blakley, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 832-340-2350 |
Stephanie Therese Chung, MBBS Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Dr. Oscar W. Brown, Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3303 Fax: 409-747-4995 |
David P Mccormick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Rt 1022, Galveston, TX 77555 Phone: 409-772-2222 |
Dr. Akila Muthukumar, M.D., Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Dr. Chanthu Pillai, MD Pediatrics - Pediatric Endocrinology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3365 Fax: 409-747-2213 |
Shivaiah Balachandra, MD Pediatrics - Pediatric Nephrology Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Dr. Roger Anthony Bartz, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-4194 |
Alok Kalia, MD Pediatrics - Pediatric Nephrology Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Dr. Alexandra Halloran, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Michael Patrick Binder, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-2222 |
Tiffany S Chan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Neel B Patel, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Marcela Navarro Holguin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-8600 Fax: 409-772-9050 |
Natalie Royer, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Primary Care Pavillion, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Rashida Aliasgar Jawadwala, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 |
Jennifer Hanke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Primary Care Pavillion, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Dr. Jennifer Nguyen, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd., Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Samantha Kay Spears, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-772-3680 |
Amy Lizette Gonzalez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 301 University Blvd, Galveston, TX 77555 Phone: 409-772-3695 Fax: 409-747-3680 |
News Archive
Impax Laboratories, Inc. today announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, in the U.S., as part of a Distribution, License, Development and Supply Agreement with AstraZeneca UK Limited.
The Biostatistics research team at the Department of Applied Mathematics, Statistics and Operational Research of the University of the Basque Country is working on applied statistics based on health sciences and experimental sciences under the leadership of Ms Inma Arostegui.
Postmastectomy radiation therapy for some breast cancer patients can reduce their risk of recurrence by almost 30 percent and increase their five-year overall survival by almost 50 percent, according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology.
Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."
› Verified 9 days ago